About Vitality Biopharma (OTCMKTS:VBIO)
Vitality Biopharma, Inc., formerly Stevia First Corp., is engaged in the development of cannabinoid prodrug pharmaceuticals. The Company unlocks the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Its product pipeline includes cannabosides, VITA-100 and VITA-210. Cannabosides are cannabinoid glycoside prodrugs. VITA-100 is an oral cannabinoid formulation containing cannabosides that is being developed for treatment of inflammatory bowel disease, epilepsy, schizophrenia, and other disorders. VITA-210 is a cannabinoid glycoside prodrug being developed primarily for treatment of pain and muscle spasticity in multiple sclerosis and in rare white matter disorders. The Company's facilities include laboratories and a manufacturing suite for good manufacturing practices (GMPs) production, which will be used for pharmaceutical-grade production of products to be tested in clinical trials.
Industry, Sector and Symbol
Trailing P/E Ratio-6.16109157769104
Forward P/E RatioN/A
Sales & Book Value
Price / Sales286.14
Price / CashN/A
Book Value$0.02 per share
Price / Book95.50
Return on EquityN/A
Return on Assets-588.47%
Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions
What is Vitality Biopharma's stock symbol?
Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."
How were Vitality Biopharma's earnings last quarter?
Vitality Biopharma Inc (OTCMKTS:VBIO) posted its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.04) earnings per share for the quarter. View Vitality Biopharma's Earnings History.
Who are some of Vitality Biopharma's key competitors?
Some companies that are related to Vitality Biopharma include Novan (NOVN), ContraFect (CFRX), Medicure (MCUJF), Trillium Therapeutics (TRIL), Gemphire Therapeutics (GEMP), Veru (VERU), Aevi Genomic Medicine (GNMX), Novelion Therapeutics (NVLN), Five Star Senior Living (FVE), Catasys (CATS), IntelGenx Technologies (IGXT), Joint (JYNT), Arch Therapeutics (ARTH), Vernalis (VNLPY), PURE Bioscience (PURE), PLx Pharma (PLXP), Alphatec (ATEC) and Acerus Pharmaceuti (TRLPF).
Who are Vitality Biopharma's key executives?
Vitality Biopharma's management team includes the folowing people:
- Avtar S. Dhillon M.D., Chairman of the Board (Age 56)
- Robert T. Brooke, Chief Executive Officer, Director (Age 36)
- Anthony E. Maida III, Ph.D., Independent Director (Age 65)
How do I buy Vitality Biopharma stock?
Shares of Vitality Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Vitality Biopharma's stock price today?
One share of Vitality Biopharma stock can currently be purchased for approximately $1.91.
How big of a company is Vitality Biopharma?
Vitality Biopharma has a market capitalization of $45.78 million and generates $160,000.00 in revenue each year. The company earns $-5,210,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. Vitality Biopharma employs 7 workers across the globe.
How can I contact Vitality Biopharma?
Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected]
MarketBeat Community Rating for Vitality Biopharma (VBIO)MarketBeat's community ratings are surveys of what our community members think about Vitality Biopharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Vitality Biopharma (OTCMKTS:VBIO) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Vitality Biopharma (OTCMKTS:VBIO) Earnings History and Estimates Chart
Vitality Biopharma (OTCMKTS VBIO) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Vitality Biopharma (OTCMKTS:VBIO) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Vitality Biopharma (OTCMKTS:VBIO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Vitality Biopharma (OTCMKTS VBIO)
No insider trades for this company have been tracked by MarketBeat.com
Vitality Biopharma (OTCMKTS VBIO) News Headlines
Vitality Biopharma (OTCMKTS:VBIO) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Vitality Biopharma (OTCMKTS:VBIO) Income Statement, Balance Sheet and Cash Flow Statement
Vitality Biopharma (OTCMKTS VBIO) Stock Chart for Tuesday, January, 16, 2018